Antimicrobial Resistance and Virulence Profiles of Acinetobacter baumannii in Pediatric Healthcare-Associated Bacteremia.

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Mohamed Mefreh, Maysaa E S Zaki, Mona Abdelaltif, Mona A E-H A El-Raouf, Ahmed H El-Nagdy, Nadia G Elrefaei, Sara G Eissa
{"title":"Antimicrobial Resistance and Virulence Profiles of Acinetobacter baumannii in Pediatric Healthcare-Associated Bacteremia.","authors":"Mohamed Mefreh, Maysaa E S Zaki, Mona Abdelaltif, Mona A E-H A El-Raouf, Ahmed H El-Nagdy, Nadia G Elrefaei, Sara G Eissa","doi":"10.7754/Clin.Lab.2025.250964","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Several factors play a role in the pathogenesis of Acinetobacter baumannii (A. baumannii). This study aimed to determine the virulence genes of A. baumannii isolated from healthcare-associated bacteremia (HAB) in pediatric patients, as well as their biofilm-forming ability and resistance to carbapenem antibiotics.</p><p><strong>Methods: </strong>One hundred isolates of A. baumannii from healthcare-associated bacteremia in children, collected be-tween January 2024 and January 2025, were subjected to biochemical identification using the API 20NE system, and confirmation of A. baumannii was performed by PCR targeting the blaOXA-51-like gene. Biofilm formation determination was quantified using the standard microtiter plate assay with crystal violet staining. Antimicrobial susceptibility testing was conducted using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar. Genetic studies using the polymerase chain reaction (PCR) were performed to detect virulence-associated genes, including bap, surA1, pld, csuE, ompA, kps, and iron acquisition genes (basD, entE, and tonB) [17-22]. Screening for carbapenemase genes (blaOXA-23, blaOXA-24/40, blaOXA-58, blaNDM) was also conducted.</p><p><strong>Results: </strong>A. baumannii was able to form strong biofilm in 20%, intermediate biofilm in 30%, and weak biofilm in 25% of the isolates. All A. baumannii isolates contained the bap and surA1 genes (100%), the pld gene (84%), and the basD gene (79%).</p><p><strong>Conclusions: </strong>The significant presence of bap and surA1 genes among all imipenem-resistant and biofilm-forming isolates highlights their central role in enhancing both virulence and antimicrobial resistance. Moreover, there are significant correlations between imipenem resistance, omp33-36, and blaOXA-40, emphasizing the combined contribution of altered membrane permeability and carbapenemase activity to resistance phenotypes. The association of biofilm formation with blaOXA-23 and basD genes further reflects a multifactorial resistance strategy.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"72 10","pages":"2195-2200"},"PeriodicalIF":0.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2025.250964","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Several factors play a role in the pathogenesis of Acinetobacter baumannii (A. baumannii). This study aimed to determine the virulence genes of A. baumannii isolated from healthcare-associated bacteremia (HAB) in pediatric patients, as well as their biofilm-forming ability and resistance to carbapenem antibiotics.

Methods: One hundred isolates of A. baumannii from healthcare-associated bacteremia in children, collected be-tween January 2024 and January 2025, were subjected to biochemical identification using the API 20NE system, and confirmation of A. baumannii was performed by PCR targeting the blaOXA-51-like gene. Biofilm formation determination was quantified using the standard microtiter plate assay with crystal violet staining. Antimicrobial susceptibility testing was conducted using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar. Genetic studies using the polymerase chain reaction (PCR) were performed to detect virulence-associated genes, including bap, surA1, pld, csuE, ompA, kps, and iron acquisition genes (basD, entE, and tonB) [17-22]. Screening for carbapenemase genes (blaOXA-23, blaOXA-24/40, blaOXA-58, blaNDM) was also conducted.

Results: A. baumannii was able to form strong biofilm in 20%, intermediate biofilm in 30%, and weak biofilm in 25% of the isolates. All A. baumannii isolates contained the bap and surA1 genes (100%), the pld gene (84%), and the basD gene (79%).

Conclusions: The significant presence of bap and surA1 genes among all imipenem-resistant and biofilm-forming isolates highlights their central role in enhancing both virulence and antimicrobial resistance. Moreover, there are significant correlations between imipenem resistance, omp33-36, and blaOXA-40, emphasizing the combined contribution of altered membrane permeability and carbapenemase activity to resistance phenotypes. The association of biofilm formation with blaOXA-23 and basD genes further reflects a multifactorial resistance strategy.

儿科保健相关菌血症中鲍曼不动杆菌的抗菌素耐药性和毒力谱
背景:几个因素在鲍曼不动杆菌(鲍曼不动杆菌)的发病机制中起作用。本研究旨在确定从儿科患者卫生保健相关菌血症(HAB)中分离的鲍曼不动杆菌的毒力基因,以及它们的生物膜形成能力和对碳青霉烯类抗生素的耐药性。方法:采用API 20NE系统对2024年1月至2025年1月采集的100株儿童卫生保健相关菌血症鲍曼不动杆菌进行生化鉴定,并采用靶向blaoxa -51样基因的PCR方法对鲍曼不动杆菌进行确证。采用结晶紫染色的标准微滴板法定量测定生物膜的形成。采用Kirby-Bauer圆盘扩散法在Mueller-Hinton琼脂上进行药敏试验。利用聚合酶链反应(PCR)进行遗传研究,检测毒力相关基因,包括bap、surA1、pld、csuE、ompA、kps和铁获取基因(basD、entE和tonB)[17-22]。筛选碳青霉烯酶基因(blaOXA-23、blaOXA-24/40、blaOXA-58、blaNDM)。结果:鲍曼不动杆菌形成强生物膜的比例为20%,中间生物膜的比例为30%,弱生物膜的比例为25%。所有鲍曼不动杆菌分离株均含有bap和surA1基因(100%)、pld基因(84%)和basD基因(79%)。结论:bap和surA1基因在所有亚胺培南耐药和生物膜形成分离株中显著存在,突出了它们在增强毒力和耐药性方面的核心作用。此外,亚胺培南抗性、omp33-36和blaOXA-40之间存在显著相关性,强调了膜通透性改变和碳青霉烯酶活性对抗性表型的共同贡献。生物膜形成与blaOXA-23和basD基因的关联进一步反映了一种多因子耐药策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书